| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.3M | — | +0.7% |
| Cost of Revenue | $1.3M | — | -4.5% |
| Gross Profit | $987K | — | +8.6% |
| R&D Expense | $414K | — | -11.8% |
| SG&A Expense | $387K | — | +0.7% |
| Operating Income | -$128K | — | +54.4% |
| Interest Expense | $31K | — | +27.5% |
| Income Tax | $0 | — | — |
| Net Income | -$153K | — | +47.8% |
| EPS (Basic) | -$0.06 | — | +45.5% |
| EPS (Diluted) | -$0.06 | — | +45.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $850K | +10.1% | +11.6% |
| Inventory | $2.8M | +6.1% | -5.0% |
| Current Assets | $4.4M | +2.4% | -23.0% |
| Total Assets | $6.7M | +0.8% | -26.9% |
| Current Liabilities | $1.1M | +27.2% | -6.1% |
| Long-term Debt | $1.0M | -1.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$129K | — | -28.9% |
| Capital Expenditures | $5K | — | — |
| Investing Cash Flow | -$20K | — | -6.6% |
| Financing Cash Flow | -$28K | — | -106.9% |
| Free Cash Flow | -$135K | — | -34.3% |
| -5.0% |
| Total Liabilities | $2.8M | +7.9% | -5.1% |
| Stockholders' Equity | $4.0M | -3.7% | -37.1% |